NewsLocal News


Eli Lilly offering $35 insulin co-pay in response to COVID-19 crisis

Lilly purchases gene therapy company
Posted at 12:29 PM, Apr 07, 2020
and last updated 2020-04-07 12:54:32-04

INDIANAPOLIS — In response to the COVID-19 epidemic, Eli Lilly and company introduced a new saving program Tuesday that will allow anyone with commercial or no insurance to get discounted insulin.

The Lilly Insulin Value program will fill your monthly prescription of Lilly insulin for just $35. The program begins Tuesday and covers most Lilly insulins, including all Humalog formulations.

To get your LIV card, call the Lilly Diabetes Solution Center at 833-808-1234 anytime between 8 a.m. and 8 p.m. Monday through Friday. A representative there can help you get a card through either email or the mail. If you already have a co-pay card from Lilly for an amount higher than $35, you can use that to get your insulin at the new discounted price.

"Too many people in the U.S. have lost their jobs because of the COVID-19 crisis, and we want to make sure no one goes without their Lilly insulin," said Mike Mason, president, Lilly Diabetes. "We've been providing affordability solutions for a long time, but more is needed to help people during this unprecedented period. People with commercial insurance, as well as those without insurance at all, are eligible, and the process is quick and simple. We want people who need help to call us."

Because of federal guidelines, seniors with Medicare Part D plans are not eligible for a co-pay card, but they may be eligible for other programs. Lilly suggests calling the Solution Center to see you are eligible for another option, such as donated insulin for people with lower incomes or the Insulin Lispro Injection with a 50 percent lower list price.

"The Lilly Insulin Value Program is meant to help address the needs of people in this crisis, but we also remain committed to exploring additional solutions that provide meaningful impact for those living with diabetes beyond the current crisis," said Mason.

The program is not available to patients with government insurance such as Medicaid, Medicare, Medicare Part D, TRICARE®/CHAMPUS, Medigap, DoD, or any State Patient or Pharmaceutical Assistance Program.